U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385236) titled 'Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping' on April 2.
Brief Summary: In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples.
By evaluating response to 2 different biologic therapies, this study has the potential to provide an in-depth understanding of the mechanisms underlying severe asthma that will inform and change treatment decisions, and may ultima...